Investing.com - Blue Water Vaccines (NASDAQ: BWV) reported first quarter EPS of $-0.18, $0.02 better than the analyst estimate of $-0.20. Revenue for the quarter came in at $0 versus the consensus estimate of $0.
Blue Water Vaccines's stock price closed at $1.04. It is down -20.00% in the last 3 months and down -74.63% in the last 12 months.
Blue Water Vaccines saw positive EPS revisions and negative EPS revisions in the last 90 days. See Blue Water Vaccines's stock price’s past reactions to earnings here.
According to InvestingPro, Blue Water Vaccines's Financial Health score is "weak performance".
Check out Blue Water Vaccines's recent earnings performance, and Blue Water Vaccines's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar